94877 ⎘
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Sub-classes:TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES
#2USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#3USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#4ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE
#5NANOMATERIALS
#6IONIZABLE LIPIDS
#7SWEETENER COMPOSITIONS
#8CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS
#9Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors
#10(DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME
#11USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#12LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#13TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
#14FUNGICIDAL ARYL AMIDINES
#15COMPOUNDS AND METHODS
#16Treprostinil derivative compounds and methods of using same
#17NANOMATERIALS COMPRISING ESTER-LINKED ACETALS
#18TOTAL SYNTHESES OF SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS), STRUCTURAL ISOMERS AND STRUCTURAL ANALOGS
#19Biphenyl Derivatives
#20(Di)amination of activated allene compounds, derivatives thereof, and methods for synthesis of the same
#21DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
#22CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS
#23Lithium-ion battery and apparatus
#24Treprostinil derivative compounds and methods of using same
#25PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS
#26Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
#27Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors
#28NANOMATERIALS
#29Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
#30Lithium-ion battery and apparatus
#31Indole derivatives and their use as protein kinase inhibitors
#32Treprostinil derivative compounds and methods of using same
#33DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#34Treprostinil derivative compounds and methods of using same
#35Non-aqueous electrolyte solution additive, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same
#36Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
#37LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#38Treprostinil derivative compounds and methods of using same
#39Crystalline forms of neurotrophin mimetic compounds and their salts
#40Indole derivatives and their use as protein kinase inhibitors
#41Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#42Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#43ELECTROLYTIC SOLUTION, METHOD FOR PREPARING ESTER COMPOUND CONTAINED THEREIN AND LITHIUM SECONDARY CELL
#44COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES
#45Treprostinil derivative compounds and methods of using same
#46Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#47Treprostinil derivative compounds and methods of using same
#48Crystalline forms of neurotrophin mimetic compounds and their salts
#49Crystalline forms of neurotrophin mimetic compounds and their salts
#50Polymerizable polar compound, liquid crystal composition, and liquid crystal display element
#51Isoprenyl compounds and methods thereof
#52Treprostinil derivative compounds and methods of using same
#53BIS(PHOSPHINE)-CARBODICARBENE CATALYST COMPLEXES AND METHODS OF USING THE SAME
#54Treprostinil derivative compounds and methods of using same
#55Isoprenyl compounds and methods thereof
#56Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#57Cationic lipid
#58Treprostinil derivative compounds and methods of using same
#59Reactive ionic liquids
#60ELECTROLYTIC SOLUTION, METHOD FOR PREPARING ESTER COMPOUND CONTAINED THEREIN AND LITHIUM SECONDARY CELL
#61METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES
#62Treprostinil derivative compounds and methods of using same
#63Deuterium substituted fumarate derivatives
#64Merocyanine derivatives
#65Isoprenyl compounds
#66Certain chemical entities, compositions, and methods
#67Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
#68Crystalline forms of neurotrophin mimetic compounds and their salts
#69Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#70CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#71Polymer film, ultraviolet absorber, merocyanine compound and process for preparing merocyanine compound
#72Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
#73Piperazinyl derivatives useful as modulators of the neuropeptide Y receptor
#74Reactive ionic liquids
#75Method for the production of halogen-substituted 2-(aminomethylidene)-3-oxobutyric acid esters
#76Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
#77Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#78Synthesis and biological activities of new tricyclic--enones (TBEs)
#79Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
#804-phenylpiperazine derivatives with functionalized linkers as dopamine Dreceptor selective ligands and methods of use
#81Certain chemical entities, compositions and methods
#82Isoprenyl compounds and methods thereof
#83Certain Chemical Entities, Compositions, and Methods
#84Phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of T-type calcium ion channel containing the same as an active ingredient
#852-FLUORINATED ACYL-3-AMINOACRYLONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
#86Imidazopyridinyl benzamide mitotic kinesin inhibitors
#87Imidazopyridinyl benzamide mitotic kinesin inhibitors
#88CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#89DIAMINE DERIVATIVE
#90Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
#91Certain chemical entities, compositions, and methods
#92Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein
#93Process for producing δ-aminopentadienoate compound
#94Novel cannabinoids and methods of use
#95Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
#96Certain indanyl urea modulators of the cardiac sarcomere
#97Imidazoyl-benzamide anti-cancer agents
#98Polypharmacophoric agents
#99Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#100Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
#101N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#102Substituted p-diaminobenzene derivatives
#103Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#104Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#105Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
#106Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
#107Merocyanine derivatives for cosmetic use
#1084-(diarylmethyl)-1-piperazinyl derivatives
#109Phenyl-piperazine derivatives as serotonin reuptake inhibitors